Trial site
Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH
- 32running trials
- 25closed trials
The trials here
What the 60 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis13 trials
- Childhood cancers8 trials
- Epilepsy4 trials
- Bladder cancer3 trials
- Chronic kidney disease3 trials
- Idiopathic pulmonary fibrosis3 trials
- Prostate cancer3 trials
- Acute lymphoblastic leukaemia2 trials
- Alzheimer disease2 trials
- Atopic dermatitis (eczema)2 trials
- Crohn's disease2 trials
- Heart failure2 trials
- and 19 more
- Phase
- Phase 343 trials
- Phase 211 trials
- Phase 2/34 trials
- Phase 12 trials
- Status
- Completed25 trials
- Active, not recruiting23 trials
- Recruiting9 trials
- Suspended3 trials
- Lead sponsor
- Novo Nordisk A/S5 trials
- AbbVie4 trials
- Amgen Inc.4 trials
- Bayer4 trials
- GPOH gGmbH4 trials
- and 29 more
Running trials
Active, not recruiting
Active, not recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
Active, not recruiting
Study of GS-5290 in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Enrolling by invitation
Active, not recruiting
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers3 recruiting
- Epilepsy3 recruiting
- Bladder cancer1 recruiting
- Crohn's disease1 recruiting
- Lung cancer1 recruiting
- Sarcoma1 recruiting
Closed trials
Completed
Completed
Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis
Active, not recruiting
Completed
Completed
Completed
Completed
Terminated
A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome
Completed
Recruiting
Recruiting
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Active, not recruiting
Completed
Completed
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
Recruiting
Completed
Active, not recruiting
Completed
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
Completed
Completed
Active, not recruiting
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026